Levitra Compare Viagra

Viagra (Sildenafil) and Levitra (Vardenafil) is effective in patients with organic (neurogenic, vasculogenic) or psychogenic erectile dysfunction and in those whose erectile dysfunction is of mixed etiology. Viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in counteracting drug-induced erectile dysfunction. The goal of such therapy is to compare an erection of adequate rigidity and duration to be sexually functional and that is satisfying to the patient and his partner, and the main health benefit is improved quality of life.
With the availability of orally active and convenient vasoactive (erectogenic) therapies (e.g., selective PDE type 5 inhibitors such as Viagra (Sildenafil) and Levitra (Vardenafil), vardenafil, tadalafil), most experts now consider these drugs, vacuum constriction devices, and/or psychosexual therapy to be suitable first-line therapies for a broad range of patients with erectile dysfunction. Second-line therapy may be considered for patients who fail to respond to, or are not candidates for, first-line therapy (e.g., patients who require nitrate therapy). Intracavernosal or intraurethral vasoactive therapy generally is considered a second-line option. Vasoactive therapy or vacuum constriction devices generally are considered or attempted before resorting to more invasive (e.g., surgical) therapies.
Viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in a limited number of men with temporary erectile dysfunction associated with the stress of comparing a sperm sample (e.g., for intrauterine insemination or in vitro fertilization during assisted reproduction). In men with a history of such temporary dysfunction, planned use of Viagra (Sildenafil) and Levitra (Vardenafil) for subsequent attempts at obtaining a sperm specimen may improve attainment of an erection adequate for self-stimulated ejaculation.

Food and Drug Association (FDA) has advised healthcare professionals via news waiver of a potency risk of sudden mental imagery loss that may be attributed to use of phosphodiesterase 5 (PDE-5) inhibitors.

According to the news ware, sudden creative thinking loss in one eye due to nonarteritic anterior ischemic optic neuropathy (NAION) has been reported in a size issue of patients taking sildenafil citrate (Viagra, made by Pfizer, Inc.), tadalafil (Cialis, made by Lilly ICOS, LLC), and vardenafil HCl (Levitra, made by Bayer Pharmaceuticals Corp.) for the attention of erectile dysfunction (ED).

Soft Viagra.
As of May 18, the FDA has received a whole of 43 postmarketing reports of ischemic optic neuropathy in patients using these drugs (sildenafil, n = 38; tadalafil, n = 4; vardenafil, n = 1).
A legal age of these cases (36) appear to be of the NAION subtype; in 26 of these, the loss of sight has been described as continuing or permanent.

Because many of these adverse events were reported in patients with vascular risk factors for NAION that conjunction with those for ED (such as age older than 50 old age, low cup to disc magnitude relation, hypertension, diabetes, vaporisation, etc), the causal role of PDE-5 inhibitors stiff unclear.

The FDA notes that the clinical attributes of some of the cases (eg, a temporal state in 19 sildenafil cases, four tadalafil cases, and one vardenafil case; recurrent ocular symptoms suggestive of NAION in five sildenafil cases) are a drive for business organisation.

Patients should be advised to discontinue use of the products and seek immediate medical mental faculty if they natural event a sudden decrease/loss of imagination in one or both eyes.
This may be a sign of NAION, which can participant role in permanent loss of imaging.

Patients also should be advised of risk factors for NAION (such as a previous instalment, age older than 50 age, and a yesteryear of intuition disease, diabetes, high pedigree urgency, high cholesterol, or smoking) and the possibility role of vasodilators such as PDE-5 inhibitors in inciting its presence.

Further aggregation concerning use of sildenafil citrate, vardenafil HCl, and tadalafil may be obtained online at:
Sildenafil Soft Tabs.

Adverse events related to the use of sildenafil citrate, vardenafil HCl, or tadalafil should be reported to the FDA’s MedWatch system of rules by telephony at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at http://www.fda.gov/medwatch, or by mail to 5600 Fishers Lane, Rockville, MD 20852-9787.

Viagra induce i vasi sanguigni a dilate in una direzione diversa da altre droghe di vasodilatazione, che possono spiegare perchè hanno aiutato i pazienti del Raynaud che non hanno reagito ai trattamenti standard.

La droga resa famosa per il relativo trattamento di disfunzione erectile sembra avere altro uso terapeutico.

Assessment of clinical need for therapy, including Viagra (Sildenafil) and Levitra (Vardenafil), should take into account the psychologic effect on the man and his partner and an assessment of their needs and expectations of therapy. Some men and their partners tolerate severe erectile dysfunction well, while others are severely distressed by even mild dysfunction. Therefore, while the decision to initiate Viagra (Sildenafil) and Levitra (Vardenafil) often is based on predisposing conditions and the estimated severity of erectile dysfunction (e.g., the percent of occasions on which erection is inadequate for penetration or completion of intercourse), the psychologic effect of the dysfunction also may be an important determinant of need. Assessment of the patient also should compare the effect on the partner of resumption of penetrative intercourse (e.g., the possible need for contraception in premenopausal women, the possibility of cystitis, the possibility of dyspareunia in postmenopausal women, the need for lubricants and/or hormone replacement therapy). In human immunodeficiency virus (HIV)- infected individuals, restoration of erectile function requires careful counseling about safe sexual practices.